Medication info

Osolez (Cholecalciferol)

Prescription medicationInjectionsIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Youyu Pharmaceutical Co., Ltd.
Appearance
A transparent liquid that is light yellow, contained in a brown glass ampoule as an injectable solution.
Packaging
0.5 milliliter/ampoule [0.5mL × 5 ampoules], 1 milliliter/ampoule [1mL × 5 ampoules]
Approval status
Active

MFDS item code 202000450 · Notified 2020.01.29

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, adjusting the dose based on measurement of the blood 25-hydroxyvitamin D level. In adults, the treatment effect and tolerability should be assessed within 3 months after administration of this medicine, and whether to repeat the dose should be determined based on this assessment. Since adverse reactions increase with overdose, do not administer more than the required dose. Adults: Intramuscularly inject 200,000IU of cholecalciferol. Elderly patients: Intramuscularly inject 100,000IU of cholecalciferol. Do not exceed an annual dose of 600,000IU of cholecalciferol.
Child administration
In adolescents, the treatment effect and tolerability should be assessed within 6 months, and whether to repeat the dose should be determined based on this assessment. Adolescents: Intramuscularly inject 200,000IU of cholecalciferol.

Ingredients

Manufacturer
Youyu Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

View approved original text

This medication is used to prevent and treat vitamin D deficiency in elderly patients, adolescents, and adults. Vitamin D plays an important role in bone health and calcium absorption; therefore, this medicine helps maintain bone density and prevent bone weakness. It is effective in improving various health issues caused by vitamin D deficiency.

How it is given

Adult administration

Use as prescribed by a physician, adjusting the dose based on measurement of the blood 25-hydroxyvitamin D level. In adults, the treatment effect and tolerability should be assessed within 3 months after administration of this medicine, and whether to repeat the dose should be determined based on this assessment. Since adverse reactions increase with overdose, do not administer more than the required dose. Adults: Intramuscularly inject 200,000IU of cholecalciferol. Elderly patients: Intramuscularly inject 100,000IU of cholecalciferol. Do not exceed an annual dose of 600,000IU of cholecalciferol.

Child administration

In adolescents, the treatment effect and tolerability should be assessed within 6 months, and whether to repeat the dose should be determined based on this assessment. Adolescents: Intramuscularly inject 200,000IU of cholecalciferol.

Precautions

This medication contains vitamin D; therefore, you must check the total vitamin D intake when using it with vitamin D fortified foods or other treatments. Regularly check calcium levels in the blood to ensure they do not become too high, and discontinue the medication if a certain threshold is exceeded. If calcium intake is high, it is essential to monitor blood and urine calcium levels more frequently. This medication should not be used by some patients, particularly those with allergies to its ingredients, hypercalcemia, kidney stones, poor kidney function, and women who are pregnant or breastfeeding. Side effects such as headaches, fatigue, muscle pain, indigestion, dehydration, increased blood pressure, kidney issues, skin rashes, etc., may occur while taking this medication, so consult a healthcare professional immediately if unusual symptoms arise. Blood vitamin D and parathyroid hormone levels should be regularly monitored to adjust the appropriate dose, especially for patients with reduced kidney function. During the administration of this medication, there may be interactions with certain anticonvulsants, steroids, diuretics, and antacids, so you must inform your healthcare provider about any other medications you are taking. Excessive vitamin D intake during pregnancy may cause adverse effects in the fetus; therefore, it is safest for pregnant and breastfeeding women to avoid using this medication. The safety and efficacy of this medication have not been adequately established for children under 12 years of age, so avoid using it in this population. In case of overdose, stop taking the medication immediately, reduce calcium intake, increase fluid intake, and seek medical assistance if necessary. Do not mix this medication with others, use it as soon as possible after opening, and dispose of any remaining medication after use. Store in a container that blocks light and maintain a room temperature of 1 to 30 degrees Celsius to preserve its efficacy.

Side effects

headache, weakness, fatigue, myalgia, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polyuria, polydipsia, dehydration, hypertension, calcium stones, calcification of tissues such as kidneys and blood vessels, kidney impairment, excessive bone calcification, arrhythmia, mental symptoms, self-awareness disorder, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, gas bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reaction, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it is important to store the medication at room temperature, specifically between 1 to 30 degrees Celsius. This will help maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

A transparent liquid that is light yellow, contained in a brown glass ampoule as an injectable solution.

Package unit

0.5 milliliter/ampoule [0.5mL × 5 ampoules], 1 milliliter/ampoule [1mL × 5 ampoules]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.